InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-B5 (LPS from E. coli 055:B5) | Macrophage-HIF1α signaling in carotid artery stenosis. | 2021 | Am J Pathol. | Kim G.D. et al. | DOI: 10.1016/j.ajpath.2021.03.008 |
| Imiquimod VacciGrade™ | Imiquimod accelerated antitumor response by targeting lysosome adaptation in ... | 2021 | J Invest Dermatol. | Chang S.H. et al. | DOI: 10.1016/j.jid.2021.01.034 |
| LPS-EB (LPS from E. coli O111:B4) | Production of IL-1β, IL-6 and CXCL8 by endometrium of crossbred heifers stimu... | 2021 | Anim Reprod Sci. | Pimenta Nunes P. et al. | DOI: 10.1016/j.anireprosci.2021.106736 |
| Plasmocin™ - Mycoplasma Elimination Reagent | Local administration of porcine immunomodulatory, chemotactic and angiogenic ... | 2021 | Bioact Mater. | Monguió-Tortajada M. et al. | DOI: 10.1016/j.bioactmat.2021.02.026 |
| Puromycin | FOXP1 drives osteosarcoma development by repressing P21 and RB transcription ... | 2021 | Oncogene | Li H. et al. | DOI: 10.1038/s41388-021-01742-4 |
| ADU-S100 | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
| 2'3'-cGAMP Control | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
| 2'3'-c-di-AM(PS)2 (Rp,Rp) VacciGrade™ | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
| PMA | Ex vivo characterization of Breg cells in patients with chronic Chagas disease. | 2021 | Sci Rep. | Girard M.C. et al. | DOI: 10.1038/s41598-021-84765-x |
| C14-Tri-LAN-Gly | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
| C12-iE-DAP | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
| IFN-α/β Reporter HEK 293 Cells | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| Blasticidin | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| QUANTI-Blue™ | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| Zeocin™ | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| LPS-B5 (LPS from E. coli 055:B5) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| Pam3CSK4 | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| QUANTI-Luc™ | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| THP1-HMGB1-Lucia™ Cells | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| QUANTI-Blue™ | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |